ALFA VETERINARY LACTATED RINGERS- sodium chloride, sodium lactate, potassium chloride and calcium chloride injection, solution
Laboratorios Alfa SRL
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Veterinary Lactated Ringers Injection, USP is a sterile, non-pyrogenic solution for fluid replenishment
in single dose containers for intravenous administration. Discard unused portion. It contains no antimicrobial agents.
|Size mL||Composition (g/100 mL)||Osmolarity(mOsmol/L)Calculated||pH||Ionic Concentration (mEq/L)||CaloricContent(Kcal/L)|
|Sodium ChlorideUSP||Sodium Lactate||PotassiumChlorideUSP||CalciumChlorideUSP||Sodium||Potasium||Calcium||Chloride||Lactate|
No venting is necessary during infusion.
Veterinary Lactated Ringer’s Injection, USP has value as a source of water, electrolytes. It is capable of inducing diuresis depending on the clinical condition of the patient.
Veterinary Lactated Ringer’s Injection, USP produces a metabolic alkalinizing effect. Lactate ions are metabolized ultimately to carbon dioxide and water, which requires the consumption of hydrogen cautions.
Veterinary Lactated Ringer’s Injection, USP is indicated as a source of water and electrolytes or as an alkalinizing agent.
Veterinary Lactated Ringer’s Injection, USP is contraindicated in patients with a known hypersensitivity to sodium lactate.
Veterinary Lactated Ringer’s Injection, USP, should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there exists edema with sodium retention.
Veterinary Lactated Ringer’s Injection, USP should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.
Veterinary Lactated Ringer’s Injection, USP should be used with great care in patients with metabolic or respiratory alkalosis. The administration of lactate ions should be done with great care in those conditions in which there is an increased level or an impaired utilization of these ions, such as severe hepatic insufficiency.
Veterinary Lactated Ringer’s Injection, USP should not be administered simultaneously with blood through the same administration set because of the likelihood of coagulation.
The container label for these injections bears the statement: Do not administer simultaneously with blood.
The intravenous administration of Veterinary Lactated Ringer’s Injection, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, over-hydration, congested states, or pulmonary edema.
The risk of dilutive states is inversely proportional to the electrolyte concentration of the injections.
The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections.
In patients with diminished renal function, administration of Veterinary Lactated Ringer’s Injection, USP may result in sodium retention proportional to the electrolyte concentrations of the injections.
Veterinary Lactated Ringer’s Injection, USP is not for use in the treatment of lactic acidosis
Keep out of the reach of children.
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
Lactated Ringer’s Injection, USP must be used with caution. Excess administration may result in metabolic alkalosis.
Caution must be exercised in the administration of veterinary Lactated Ringer’s Injection, USP to patients receiving corticosteroids or corticotrophin.
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
Do not administer unless solution is clear and both seal and container are intact.
As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient, as well as laboratory determinations.
Parenteral drug products should be inspected visually for particulate matter and discolorations prior to administration whenever solution and container permit.
All injections in plastic containers are intended for intravenous administration using sterile equipment.
Additives may be incompatible. Complete information is not available.
Those additives known to be incompatible should not be used.
Consult with pharmacist, if available. If, in the informed judgment of the veterinarian, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced.
Do not store solutions containing additives. Discard unused portion.
In an event of over hydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See Warnings, Precautions and Adverse Reactions.
Store below 30ºC (86ºF).
This is a single dose container and does not contain preservatives.
Use the solution immediately after the bottle is opened, discard the remaining one.
Squeeze and inspect the bottle, discard if leaks are found or if the solution contains visible and solid particles.
Do not administer simultaneously with blood.
Do not use it unless solution is clear and seal is intact, the solution containing dextrose may be contraindicated in patients with a known allergy to corn or corn products.
DIRECTIONS FOR USE PLASTIC CONTAINER:
Preparation and administration
1. Check for minute leaks by squeezing the container firmly. If leaks are found, discard solution as sterility may be impaired.
2. Suspend container from eyelet support.
3. Remove Plastic protector from ports area at the bottom of container.
4. Hold the bottle in vertical position and inset pyrogen free IV administration set in the outlet port. Use aseptic Technique
To Add Medication
WARNING: Additives may be incompatible.
To add medication before solution administration
1. Prepare medication site.
2. Using syringe with 18 to 21 gauge needle, puncture inlet port and inject.
3. Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.
To add medication during solution administration
1. Close clamp on the set.
2. Prepare medication site.
3. Using syringe with 18 to 21 gauge needle, puncture inlet port and inject.
4. Remove container from IV pole and/or turn to an upright position.
5. Mix solution and medication thoroughly.6. Return container to in use position and continue administration.
CAUTION: Federal law (USA) restricts this drug to use by or on the order of a licensed veterinarian.
VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.